GAFFX
Price
$75.47
Change
-$0.54 (-0.71%)
Updated
May 23 closing price
Net Assets
297.16B
VCULX
Price
$16.52
Change
-$0.14 (-0.84%)
Updated
May 23 closing price
Net Assets
1.7B
Interact to see
Advertisement

GAFFX vs VCULX

Header iconGAFFX vs VCULX Comparison
Open Charts GAFFX vs VCULXBanner chart's image
American Funds Growth Fund of Amer F3
Price$75.47
Change-$0.54 (-0.71%)
VolumeN/A
Net Assets297.16B
VALIC Company I Growth
Price$16.52
Change-$0.14 (-0.84%)
VolumeN/A
Net Assets1.7B
GAFFX vs VCULX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. VCULX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and VCULX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 297B vs. VCULX (1.7B). GAFFX pays higher dividends than VCULX: GAFFX (0.70) vs VCULX (0.05). GAFFX was incepted earlier than VCULX: GAFFX (8 years) vs VCULX (19 years). VCULX (0.78) is less costly to investors than GAFFX (0.30). VCULX is a more actively managed with annual turnover of: 44.00 vs. GAFFX (25.00). VCULX has a lower initial minimum investment than GAFFX: VCULX (0) vs GAFFX (1000000). VCULX annual gain was more profitable for investors over the last year : 9.68 vs. GAFFX (6.73). GAFFX return over 5 years is better than : 49.43 vs. VCULX (-9.77).
GAFFXVCULXGAFFX / VCULX
Total Expense Ratio0.300.6248%
Annual Report Gross Expense Ratio0.300.7838%
Fund Existence8 years19 years-
Gain YTD2.068-4.598-45%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets297B1.7B17,491%
Annual Yield % from dividends0.700.051,376%
Returns for 1 year6.739.6870%
Returns for 3 years40.7419.72207%
Returns for 5 years49.43-9.77-506%
Returns for 10 yearsN/A3.31-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EBTC38.58N/A
N/A
Enterprise Bancorp
PHI22.62N/A
N/A
PLDT
KPTI4.70N/A
N/A
Karyopharm Therapeutics Inc.
CDRE33.13-0.31
-0.93%
Cadre Holdings
E29.11-0.33
-1.12%
ENI SpA